Institutions · Entity Annotation Prototype (beta)

1articles mentioning institutions

1institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: ChiCTR2000040034 ×

ChiCTR2000040034

This institution is selected. Its supporting articles are shown below.

ChiCTR20000400341

Articles mentioning ChiCTR2000040034

1 articles · page 1 of 1

Single-cell dissection of persistent tumor antigens in non-responders reveals opportunities for TAA-targeted vaccination after neoadjuvant therapy in esophageal squamous cell carcinoma

jitc · abstract · 2026-04-22 · 1 matching annotations

84.3%

ChiCTR2000040034 paclitaxel camrelizumab cisplatin chemotherapy chemoimmunotherapy ESCC

…dvanced ESCC enrolled in a multicenter, phase 3 clinical trial (ChiCTR2000040034). Patients were randomized to receive neoadjuvant chemotherapy …

Browse institutions

ChiCTR2000040034

Articles mentioning ChiCTR2000040034

Single-cell dissection of persistent tumor antigens in non-responders reveals opportunities for TAA-targeted vaccination after neoadjuvant therapy in esophageal squamous cell carcinoma